Showing 13 to 19 of 19 results
Mia Love's Glioblastoma Worsens; Family Prioritizes Comfort Care
Former US Representative Mia Love, 49, is facing a worsening prognosis in her battle against glioblastoma brain cancer; her daughter announced that the cancer is no longer responding to treatment, and the family is prioritizing comfort care.
Mia Love's Glioblastoma Worsens; Family Prioritizes Comfort Care
Former US Representative Mia Love, 49, is facing a worsening prognosis in her battle against glioblastoma brain cancer; her daughter announced that the cancer is no longer responding to treatment, and the family is prioritizing comfort care.
Progress
4% Bias Score
Brain Tumor Vaccine Shows Promise in Phase 1 Trial
A Phase 1 clinical trial in Heidelberg and Mannheim demonstrated that a new mutation-specific vaccine targeting IDH1 mutations in diffuse gliomas yielded positive results, with 84% of the 33 participants still alive three years after treatment, and 63% showing tumor stabilization.
Brain Tumor Vaccine Shows Promise in Phase 1 Trial
A Phase 1 clinical trial in Heidelberg and Mannheim demonstrated that a new mutation-specific vaccine targeting IDH1 mutations in diffuse gliomas yielded positive results, with 84% of the 33 participants still alive three years after treatment, and 63% showing tumor stabilization.
Progress
40% Bias Score
New Focused Ultrasound Device Promises Revolution in Brain Cancer and Alzheimer's Treatment
Sunnybrook Research Institute developed a new helmet-like device using focused ultrasound to treat brain conditions like brain cancer and Alzheimer's, eliminating the need for MRI machines, significantly expanding accessibility and reducing costs; human clinical trials are planned for 2025.
New Focused Ultrasound Device Promises Revolution in Brain Cancer and Alzheimer's Treatment
Sunnybrook Research Institute developed a new helmet-like device using focused ultrasound to treat brain conditions like brain cancer and Alzheimer's, eliminating the need for MRI machines, significantly expanding accessibility and reducing costs; human clinical trials are planned for 2025.
Progress
52% Bias Score
Fox News Contributor Dr. Kelly Powers Dies from Brain Cancer at 45
Fox News contributor Dr. Kelly Powers, 45, died Sunday from brain cancer after a years-long battle that included remission, fertility treatments, and a fundraising effort for innovative treatment in Germany. She was known for her work on health issues and appeared on Fox News and Fox Business.
Fox News Contributor Dr. Kelly Powers Dies from Brain Cancer at 45
Fox News contributor Dr. Kelly Powers, 45, died Sunday from brain cancer after a years-long battle that included remission, fertility treatments, and a fundraising effort for innovative treatment in Germany. She was known for her work on health issues and appeared on Fox News and Fox Business.
Progress
36% Bias Score
Mia Love's Glioblastoma Worsens; Family Focuses on Comfort Care
Former US Representative Mia Love, the first Black Republican woman elected to Congress, is facing a worsening prognosis in her battle with glioblastoma brain cancer; her daughter announced that treatment is no longer effective and the family is prioritizing comfort care.
Mia Love's Glioblastoma Worsens; Family Focuses on Comfort Care
Former US Representative Mia Love, the first Black Republican woman elected to Congress, is facing a worsening prognosis in her battle with glioblastoma brain cancer; her daughter announced that treatment is no longer effective and the family is prioritizing comfort care.
Progress
20% Bias Score
Rollercoaster Ride Possibly Leads to Early Diagnosis of Aggressive Childhood Brain Cancer
A 13-year-old girl's medulloblastoma diagnosis, potentially triggered by a rollercoaster ride, led to early treatment before the cancer spread to her spinal cord, highlighting the importance of early detection in improving survival rates.
Rollercoaster Ride Possibly Leads to Early Diagnosis of Aggressive Childhood Brain Cancer
A 13-year-old girl's medulloblastoma diagnosis, potentially triggered by a rollercoaster ride, led to early treatment before the cancer spread to her spinal cord, highlighting the importance of early detection in improving survival rates.
Progress
44% Bias Score
Glioblastoma Death Highlights Projected 75% Increase in Cases by 2050
Fox News commentator Dr. Kelly Powers, 45, died from glioblastoma, a brain cancer projected to increase by 75 percent by 2050 due to pollution and chemical exposure; despite treatments, she passed away last week leaving behind a young son.
Glioblastoma Death Highlights Projected 75% Increase in Cases by 2050
Fox News commentator Dr. Kelly Powers, 45, died from glioblastoma, a brain cancer projected to increase by 75 percent by 2050 due to pollution and chemical exposure; despite treatments, she passed away last week leaving behind a young son.
Progress
40% Bias Score
Showing 13 to 19 of 19 results